» Articles » PMID: 25227692

Association Between the Proportion of Dominant Follicles and Oocyte Developmental Competence

Overview
Publisher Springer
Date 2014 Sep 18
PMID 25227692
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To explore the optimal timing for hCG triggering by investigating the impact of different proportion of dominant follicles on the oocyte developmental competence.

Methods: One hundred ninety-eight infertile women were divided into three groups according to the proportion of dominant follicles on hCG day: (1) low: <15% (n = 66); (2) middle: 15-27% (n = 66); (3) high: >27% (n = 66). The grouping criteria were the bottom and top tertiles of the proportion of dominant follicles.

Results: The gonadotropin dosage, duration and maximum follicle diameter in the low proportion group were lower than those in the middle and high proportion groups. Oocyte maturation and the abnormal fertilization rate in the low proportion group were lower than those in the middle and high proportion groups. The normal fertilization rate did not differ among the three groups. The cleavage rate and number of transferable embryos in the low proportion group were significantly higher than those in the high proportion group. The high-quality embryo rate, implantation rate, and pregnancy rate in the low proportion group were significantly higher than those in the middle and high proportion groups.

Conclusions: A high proportion of dominant follicles are closely associated with impaired oocyte developmental competence and low pregnancy rate. These findings suggest that follicular overgrowth induced by delayed hCG triggering may undermine oocyte developmental competence and the proportion of dominant follicles may be a potential parameters for hCG triggering.

Citing Articles

Increasing dominant follicular proportion was associated with adverse IVF/ICSI outcomes in low-prognosis women undergoing GnRH antagonist protocol: a retrospective cohort study.

Xie Q, Jiang W, Wei Y, Ni D, Yan N, Yang Y J Ovarian Res. 2024; 17(1):179.

PMID: 39217358 PMC: 11365273. DOI: 10.1186/s13048-024-01502-4.


Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol.

Xie Q, Ni D, Chen S, Zhang W, Wang J, Ling X J Ovarian Res. 2024; 17(1):56.

PMID: 38444028 PMC: 10913352. DOI: 10.1186/s13048-024-01379-3.


Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment.

Liu Y, Lin J, Shen X, Zhu Q, Kuang Y Front Endocrinol (Lausanne). 2023; 14:1072170.

PMID: 36936138 PMC: 10020617. DOI: 10.3389/fendo.2023.1072170.


Increasing dominant follicular proportion negatively associated with good clinical outcomes in normal ovarian responders using the depot GnRH agonist protocol: a large-sample retrospective analysis.

Su H, Lai Y, Li J, Liao T, Ji L, Hu X J Ovarian Res. 2022; 15(1):44.

PMID: 35418089 PMC: 9006398. DOI: 10.1186/s13048-022-00973-7.


Is there a correlation between follicle size and gene expression in cumulus cells and is gene expression an indicator of embryo development?.

Kahraman S, Pirkevi Cetinkaya C, Cetinkaya M, Tufekci M, Gokhan Ekmekci C, Montag M Reprod Biol Endocrinol. 2018; 16(1):69.

PMID: 30031399 PMC: 6054838. DOI: 10.1186/s12958-018-0388-0.

References
1.
Garrido N, Navarro J, Remohi J, Simon C, Pellicer A . Follicular hormonal environment and embryo quality in women with endometriosis. Hum Reprod Update. 2000; 6(1):67-74. DOI: 10.1093/humupd/6.1.67. View

2.
Erickson G, Danforth D . Ovarian control of follicle development. Am J Obstet Gynecol. 1995; 172(2 Pt 2):736-47. DOI: 10.1016/0002-9378(95)90147-7. View

3.
Garcia-Velasco J, Isaza V, Vidal C, Landazabal A, Remohi J, Simon C . Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod. 2001; 16(12):2533-9. DOI: 10.1093/humrep/16.12.2533. View

4.
Xia P, Younglai E . Relationship between steroid concentrations in ovarian follicular fluid and oocyte morphology in patients undergoing intracytoplasmic sperm injection (ICSI) treatment. J Reprod Fertil. 2000; 118(2):229-33. DOI: 10.1530/jrf.0.1180229. View

5.
Ectors F, Vanderzwalmen P, Van Hoeck J, Nijs M, Verhaegen G, Delvigne A . Relationship of human follicular diameter with oocyte fertilization and development after in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod. 1997; 12(9):2002-5. DOI: 10.1093/humrep/12.9.2002. View